MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-28-2026
Novartis AG PEG Ratio 2011-2026 | NVS
Annual PEG Ratio Novartis AG
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -20.8 | -6.58 | -2.23 | -1.35 | -2.13 | -0.371 | 0.125 | 1.73 | -4.41 | 5.96 | -1.21 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.96 | -20.8 | -2.84 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B |  USA |
 |
Apellis Pharmaceuticals
APLS
|
-5.4 | $ 20.22 | -2.32 % | $ 2.55 B | USA |
 |
Aptorum Group Limited
APM
|
0.0951 | $ 0.82 | -3.48 % | $ 4.47 M | China |
 |
Axsome Therapeutics
AXSM
|
-5.2 | $ 164.71 | -1.01 % | $ 8.19 B | USA |
 |
AbCellera Biologics
ABCL
|
0.0142 | $ 3.73 | -2.49 % | $ 1.11 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Burford Capital Limited
BUR
|
-0.568 | $ 8.5 | -2.63 % | $ 1.39 B | Britain |
 |
Catalyst Pharmaceuticals
CPRX
|
0.304 | $ 23.88 | - | $ 2.92 B | USA |
 |
Corvus Pharmaceuticals
CRVS
|
0.158 | $ 18.08 | 1.06 % | $ 868 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
Eton Pharmaceuticals
ETON
|
0.127 | $ 17.72 | -2.37 % | $ 454 M | USA |
 |
Exelixis
EXEL
|
-2.14 | $ 40.99 | -0.1 % | $ 11.1 B | USA |
 |
ARCA biopharma
ABIO
|
-0.0372 | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
0.0443 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
4.18 | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | USA |
 |
Galapagos NV
GLPG
|
0.0003 | $ 33.13 | -2.82 % | $ 2.69 B |  Belgium |
 |
Greenwich LifeSciences
GLSI
|
6.84 | $ 27.7 | 1.12 % | $ 361 M | USA |
 |
Genmab A/S
GMAB
|
0.277 | $ 27.67 | -6.69 % | $ 17.7 B |  Danmark |
 |
Capricor Therapeutics
CAPR
|
0.317 | $ 26.04 | -3.07 % | $ 697 M | USA |
 |
Acasti Pharma
ACST
|
-0.0483 | - | 4.01 % | $ 150 M | Canada |
 |
Codexis
CDXS
|
-0.0807 | $ 0.99 | -2.92 % | $ 72.7 M | USA |
 |
Halozyme Therapeutics
HALO
|
0.872 | $ 69.39 | -0.67 % | $ 8.32 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
0.631 | $ 28.56 | -1.19 % | $ 1.64 B | USA |
 |
ImmuCell Corporation
ICCC
|
0.0444 | $ 6.3 | -3.67 % | $ 51.5 M | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | USA |
 |
Immuron Limited
IMRN
|
4.81 K | $ 0.75 | -0.69 % | $ 6.43 M |  Australia |
 |
Immatics N.V.
IMTX
|
2.14 K | $ 9.86 | -1.3 % | $ 620 M | Germany |
 |
Immunic
IMUX
|
0.0859 | $ 1.1 | 3.3 % | $ 171 M | USA |
 |
Immunovant
IMVT
|
0.000003 | $ 26.99 | -2.74 % | $ 4.09 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
Inhibrx
INBX
|
-0.158 | $ 75.96 | -1.97 % | $ 3.58 B | USA |
 |
InMed Pharmaceuticals
INM
|
1.55 | $ 0.75 | -8.49 % | $ 1.84 M | Canada |
 |
INmune Bio
INMB
|
-0.342 | $ 1.41 | 6.07 % | $ 25.4 M | USA |
 |
Insmed Incorporated
INSM
|
-1.28 | $ 146.89 | 0.39 % | $ 29.2 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-0.000777 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
-0 | $ 3.19 | -4.49 % | $ 1.14 M | USA |
 |
Innate Pharma S.A.
IPHA
|
-0.0174 | $ 1.63 | -1.21 % | $ 235 M |  France |
 |
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M |  Israel |
 |
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
-0.339 | $ 29.11 | -0.31 % | $ 1.69 B | USA |